ResMed Inc.— Sankey Diagram
Annual mode · period ending 2026-03-31 · SEC EDGAR
FY2026 - Q4(Jan 26 · Feb 26 · Mar 26)
Total Assets
$8.78B
↑+16.1% +$1.22Bvs FY2025
Total Liabilities
$2.29B
↑+13.4% +$272Mvs FY2025
Equity
$6.49B
↑+17.1% +$946Mvs FY2025
Cash
$1.66B
↑+78.0% +$728Mvs FY2025
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $8.78B | $7.57B |
| Current Assets | $4.06B | $3.21B |
| Cash | $1.66B | $933M |
| ST Investments | $0 | $0 |
| Receivables | $999M | $908M |
| Inventory | $912M | $863M |
| Other Current | $493M | $505M |
| Non-Current Assets | $4.72B | $4.36B |
| PPE | $567M | $535M |
| Goodwill | $3.04B | $2.85B |
| Intangibles | $425M | $430M |
| Investments | $0 | $0 |
| Other Non-Current | $685M | $544M |
| Total Liab+Eq | $8.78B | $7.57B |
| Current Liab. | $1.35B | $941M |
| Accounts Payable | $273M | $223M |
| Short-Term Debt | $260M | $10M |
| Deferred Revenue | $179M | $160M |
| Other CL | $639M | $548M |
| Non-Current Liab. | $941M | $1.08B |
| Long-Term Debt | $404M | $663M |
| Other LT Liab. | $537M | $417M |
| Equity | $6.49B | $5.55B |
| Retained Earnings | $6.96B | $5.78B |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · RMD · Comparing FY2026 vs FY2025